Combination testing paradigm would reduce novel regimen testing time from decades to years
Early clinical trial results are promising for a new combination tuberculosis (TB) drug therapy that is proving potent and could reduce treatment time to just four months for patients with drug-sensitive TB as well as many drug-resistant strains…
AIDS organizations respond to Secretary of State Hillary Clinton’s speech and proposed blueprint
The U.S. government will be releasing an “AIDS-Free Generation Blueprint” detailing their plans to bring an end to the AID pandemic before the next World AIDS Day – Dec. 1, 2012 – according to a speech by Secretary of State Hillary Clinton Monday at the International AIDS Conference (IAC) in Washington…
“First let me say five words that we have not been able to say for far too long – welcome to the United States,” Secretary of State Hillary Clinton told an audience of thousands Monday at the International AIDS Conference (IAC) in Washington, referring to the ban that was lifted in 2008 allowing HIV infected […]
The following guest post from IAVI President and CEO Margaret McGlynn, AVAC Executive Director Mitchell Warren and UNAIDS Executive Director Michel Sidibe comes on the release of Investing to End the AIDS Epidemic: A New Era for HIV Research & Development, a report from the HIV Vaccine & Microbicides Resource Tracking Working Group. Close to […]
Of the nearly 16 million injection drug users worldwide, approximately 3 million are living with HIV. And if sub-Saharan Africa is excluded, thirty percent of global HIV cases are attributed to injection drug use and in some cases is the main means of HIV transmission. Dr. Nora Volkow, director of the National Institute on Drug […]
Vanessa Kerry, the daughter of Senator John Kerry of Massachusetts and his first wife, Julia Thorne, is a doctor working at Massachusetts General Hospital and founder of the non-profit Global Health Service Corps. Her organization has partnered with the Peace Corps to develop the Global Health Service Partnership. The partnership will send health professionals abroad to work as medical […]
HIV
Amid unprecedented challenges to routine healthcare access, trial results mark a first for a critically needed HIV prevention measure An investigational drug administered by injection every […]
Tuberculosis
In the six weeks before South Africa responded its first diagnoses of COVID-19 with the start of physical distancing measures, more than 47,000 people on average […]
Research & Development
What we have learned from HIV can guide responses to COVID-19 that are innovative, effective and inclusive, and can help end the pandemic faster The following […]
Policy
The following is a guest post by Kenneth G. Castro, MD, FIDSA Since its formation in 1948, WHO has relied heavily on the U.S. for collaborations […]